Medtech startup Corryn Biotechnologies is leading a new wave in wound care innovation. Co-founded by Luke Burke and backed by investors like the British Design Fund, the company has secured £150,000 to advance its groundbreaking wound care technology.
- Investment Secured: The British Design Fund invested £150K in Corryn, contributing to their £550K Seed funding round.
- Clinical Trials Soon: With the new funding, the company plans to initiate its first clinical trial by the end of next year. Their research and manufacturing center in Port Talbot, South Wales, is equipped to meet demand until 2030.
- Global Expansion: They target the US and European markets, recognizing significant growth potential in these regions.
- Investor Confidence: Damon Bonser, CEO of the British Design Fund, expressed excitement about Corryn’s potential to revolutionize chronic wound care on a global scale.
With visionary leadership and strong investment, Corryn Biotechnologies is set to reshape the future of wound care, improving outcomes for patients worldwide.
